Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01861119Phase 3Completed
Phase 3, randomised trial of kelocote and allium cepa extract in Hypertrophic Scar (HS) and keloid (3 arms), sponsored by CHA University. Primary endpoints: Vancouver Scar Scale at 3 months and Body Image Questionnaire at 3 months. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01861119.